Bristol-Myers Squibb Company
BMY
$59.01
-$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| Weiss Ratings | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.20 | |||
| Price History | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.35% | |||
| 30-Day Total Return | -0.22% | |||
| 60-Day Total Return | 5.85% | |||
| 90-Day Total Return | 5.87% | |||
| Year to Date Total Return | 3.95% | |||
| 1-Year Total Return | 13.04% | |||
| 2-Year Total Return | -12.25% | |||
| 3-Year Total Return | -16.61% | |||
| 5-Year Total Return | 18.51% | |||
| 52-Week High % Change | -4.82% | |||
| 52-Week Low % Change | 53.19% | |||
| Price | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $63.33 | |||
| 52-Week Low Price | $39.35 | |||
| 52-Week Low Price (Date) | Jul 05, 2024 | |||
| 52-Week High Price (Date) | Mar 11, 2025 | |||
| Valuation | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 122.33B | |||
| Enterprise Value | 162.46B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -4.43 | |||
| Earnings Per Share Growth | -214.81% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.54 | |||
| Price/Book (Q) | 7.49 | |||
| Enterprise Value/Revenue (TTM) | 3.36 | |||
| Price | $59.01 | |||
| Enterprise Value/EBITDA (TTM) | 8.35 | |||
| Enterprise Value/EBIT | 16.45 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.04B | |||
| Dividend Yield | 4.01% | |||
| Div. Per Share (Most Recent) | $0.62 | |||
| Dividend Per Share (TTM) | $2.42 | |||
| Payout Ratio (TTM) | -54.35% | |||
| Dividend Per Share (Most Recent) | $0.62 | |||
| Company Info | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 609 252 4621 | |||
| Address | Route 206 & Province Line Road Princeton, NJ 08543 | |||
| Website | www.bms.com | |||
| Country | United States | |||
| Year Founded | 1887 | |||
| Profitability | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 20.44% | |||
| Profit Margin | -18.52% | |||
| Management Effectiveness | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.57% | |||
| Return on Equity | -- | |||
| Income Statement | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 48.30B | |||
| Total Revenue (TTM) | 48.30B | |||
| Revenue Per Share | $23.71 | |||
| Gross Profit (TTM) | 36.35B | |||
| EBITDA (TTM) | 19.45B | |||
| EBIT (TTM) | 9.88B | |||
| Net Income (TTM) | -8.95B | |||
| Net Income Avl. to Common (TTM) | -8.95B | |||
| Total Revenue Growth (Q YOY) | 7.54% | |||
| Earnings Growth (Q YOY) | -95.69% | |||
| EPS Diluted (TTM) | -4.43 | |||
| EPS Diluted Growth (Q YOY) | -95.91% | |||
| Balance Sheet | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 10.86B | |||
| Cash Per Share (Q) | $5.33 | |||
| Total Current Assets (Q) | 29.78B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 16.39B | |||
| Current Ratio (Q) | 1.253 | |||
| Book Value Per Share (Q) | $8.05 | |||
| Total Assets (Q) | 92.60B | |||
| Total Current Liabilities (Q) | 23.77B | |||
| Total Debt (Q) | 51.26B | |||
| Total Liabilities (Q) | 76.22B | |||
| Total Common Equity (Q) | 16.34B | |||
| Cash Flow | BMY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -21.35B | |||
| Cash from Financing (TTM) | 5.13B | |||
| Net Change in Cash (TTM) | -1.17B | |||
| Levered Free Cash Flow (TTM) | 17.59B | |||
| Cash from Operations (TTM) | 15.19B | |||
